ZCA
MRNA icon

Zeke Capital Advisors’s Moderna MRNA Stock Holding History

Zeke Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$426K Buy
+2,370
New +$388K 0.03% 265
2022
Q2 		– Sell
-1,511
Closed -$260K – 515
2022
Q1 		$260K Buy
+1,511
New +$254K 0.01% 412

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zeke Capital Advisors's MRNA Position: Q4 2022 in Review

Zeke Capital Advisors opened a new position in Moderna (MRNA) in Q4 2022: 2,370 shares worth $426K. The stake represents 0.03% of the portfolio and ranks #265 among its holdings. This is a return to the name: Zeke Capital Advisors previously reported a position in MRNA as recently as Q1 2022.

Zeke Capital Advisors first reported a position in MRNA in Q1 2022 and has held it in 2 quarters since. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Zeke Capital Advisors held 2,370 shares of Moderna worth $426K as of Q4 2022.
  • Moderna was a new Zeke Capital Advisors position in Q4 2022.
  • Moderna made up 0.03% of Zeke Capital Advisors's portfolio in Q4 2022, its #265 holding.
  • Zeke Capital Advisors first reported a position in Moderna in Q1 2022 and has held it in 2 quarters since.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.